Blood-pressure drugs linked to bowel cancer
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.UP TO one-fifth of bowel cancer cases may be linked to blood-pressure drugs and sleeping pills or tranquillisers, a Danish study of more than 5,000 middle-aged men says.
The study found that the use of these drugs appeared to triple the risk of cancer of the colon - part of the large bowel - and the researchers claim that there is evidence that the drugs have a direct toxic effect.
The incidence of colon cancer in Denmark since the 1940s has increased by about 40 per cent and over the same period the use of anti-hypertensive drugs and sedatives has become widespread, the researchers said, writing in the Scandinavian Journal of Gastroenterology. About 10 per cent of the population are receiving drug treatment for blood pressure.
The study followed a group of 5,249 men, aged 40 to 59, over 18 years. They had been recruited initially to take part in a heart study. Colon cancer was diagnosed in 51 men and rectal cancer in 42 of them.
The drugs appeared to be a 'strong risk factor' for colon cancer, but more research was needed to prove a causal link, the researchers said.
Dr Richard Gray, a senior research fellow at the Imperial Cancer Research Fund's cancer studies unit in Oxford, said that the benefits of blood pressure treatment outweighed potential risks. 'The number of cancers in the study was small,' he said.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments